Bard Associates Inc Nuwellis, Inc. Transaction History

Bard Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.56 - $2147.95 $1,120 - $4.3 Million	-2,000 Reduced 0.45%	438,818 $237,000
Q2 2022 Aug 11, 2022	SELL	$0.48 - $1.12 $960 - $2,240	-2,000 Reduced 0.45%	440,818 $260,000
Q1 2022 May 11, 2022	BUY	$0.85 - $1.27 $13,600 - $20,320	16,000 Added 3.75%	442,818 $447,000
Q4 2021 Feb 14, 2022	SELL	$1.13 - $2.26 $7,344 - $14,689	-6,500 Reduced 1.5%	426,818 $487,000
Q3 2021 Nov 12, 2021	BUY	$2.12 - $4.6 $549,928 - $1.19 Million	259,400 Added 149.15%	433,318 $953,000
Q2 2021 Aug 12, 2021	BUY	$3.53 - $5.98 $613,930 - $1.04 Million	173,918 New	173,918 $730,000

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $55.8M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.